Germany· DE-A57-c231b672fff031f2
Diprosone Depot 1 Ml Ampulle
A medicinal product containing betamethasone dipropionate, betamethasone sodium phosphate, registered in Germany by Organonhealthcare Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Betamethasone Dipropionate, Betamethasone Sodium Phosphate
- Manufacturer
- Organonhealthcare Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Betamethasone dipropionate, betamethasone sodium phosphate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBetaloan SUIKAdvanced Rx Pharmacy of Tennessee, LLC
- NorwayCelestan DepotOrganon Healthcare GmbH
- FinlandCeleston ChronodoseN.V. Organon
- IcelandDiprospanN.V. Organon*
- SwedenCeleston bifas 5,7 mg/ml Injektionsvätska, suspensionNV Organon
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Celestan Biphase, Diprophos
- Belgium · Celestone Chronodose, Diprophos Ampoule
- Bulgaria · Дипрофос
- Denmark · Diprospan
- Spain · Celestone Cronodose
- Finland · Celeston Chronodose
- France · Celestene Chronodose, Diprostene
- Greece · Celestone Chronodose, Propiochrone
- Hungary · Diprophos
- Iceland · Diprospan
- Luxembourg · Celestone Chronodose, Diprophos Ampoule
- Netherlands · Celestone Chronodose
- Norway · Celeston Chronodose
- Poland · Diprophos
- Portugal · Diprofos Depot
- Romania · Diprophos
- Sweden · Celeston Bifas
- Slovakia · Diprophos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d0ef7396-3eed-43e7-9712-18f64f289fcb GET /v1/drugs/d0ef7396-3eed-43e7-9712-18f64f289fcb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Infiltration ,Intraarticular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Betamethasone Dipropionate, Betamethasone Sodium Phosphate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about betamethasone dipropionate, betamethasone sodium phosphate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.